Therapeutic efficacy of dendritic cell vaccine combined with programmed death 1 inhibitor for hepatocellular carcinoma.

Teng, Chiao-Fang; Wang, Ting; Shih, Fu-Ying; Shyu, Woei-Cherng; Jeng, Long-Bin

Teng, Chiao-Fang; Wang, Ting; Shih, Fu-Ying; Shyu, Woei-Cherng; Jeng, Long-Bin.

Afiliação

Teng CF; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
Wang T; Organ Transplantation Center, China Medical University Hospital, Taichung, Taiwan.
Shih FY; Research Center for Cancer Biology, China Medical University, Taichung, Taiwan.
Shyu WC; Organ Transplantation Center, China Medical University Hospital, Taichung, Taiwan.
Jeng LB; Ph.D. Program for Biotech Pharmaceutical Industry, School of Pharmacy, China Medical University, Taichung, Taiwan.

J Gastroenterol Hepatol ; 36(7): 1988-1996, 2021 Jul.

Article em En | MEDLINE | ID: mdl-33462840

Assuntos

Carcinoma Hepatocelular; Neoplasias Hepáticas; Vacinas; Animais; Carcinoma Hepatocelular/tratamento farmacológico; Células Dendríticas/imunologia; Humanos; Inibidores de Checkpoint Imunológico; Neoplasias Hepáticas/tratamento farmacológico; Camundongos; Receptor de Morte Celular Programada 1; Vacinas/uso terapêutico

Palavras-chave

combination treatment; dendritic cells; hepatocellular carcinoma; immune checkpoint inhibitor; programmed death 1

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas / Carcinoma Hepatocelular / Neoplasias Hepáticas Limite: Animals / Humans Idioma: En Revista: J Gastroenterol Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Taiwan

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google